Immunocore Holdings plc NASDAQ:IMCR

Immunocore Holdings stock price today

$32.34
+3.16
+10.83%
Financial Health
0
1
2
3
4
5
6
7
8
9

Immunocore Holdings stock price monthly change

-26.15%
month

Immunocore Holdings stock price quarterly change

-26.15%
quarter

Immunocore Holdings stock price yearly change

-58.01%
year

Immunocore Holdings key metrics

Market Cap
1.41B
Enterprise value
2.11B
P/E
-44.31
EV/Sales
14.68
EV/EBITDA
-66.55
Price/Sales
12.05
Price/Book
6.21
PEG ratio
-0.62
EPS
-1.28
Revenue
275.38M
EBITDA
-35.27M
Income
-63.02M
Revenue Q/Q
58.28%
Revenue Y/Y
66.09%
Profit margin
-28.68%
Oper. margin
-27.56%
Gross margin
99.68%
EBIT margin
-27.56%
EBITDA margin
-12.81%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Immunocore Holdings stock price history

Immunocore Holdings stock forecast

Immunocore Holdings financial statements

Average Price Target
Last Year

$70.2

Potential upside: 117.06%

Based on estimate of 5 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Immunocore Holdings plc (NASDAQ:IMCR): Profit margin
Jun 2023 47.76M -14.07M -29.47%
Sep 2023 51.48M 1.90M 3.7%
Dec 2023 105.63M -26.41M -25.01%
Mar 2024 70.50M -24.43M -34.66%
Immunocore Holdings plc (NASDAQ:IMCR): Debt to assets
Jun 2023 440360000 163.08M 37.03%
Sep 2023 464119000 172.57M 37.18%
Dec 2023 597001000 228.15M 38.22%
Mar 2024 993987000 634.45M 63.83%
Immunocore Holdings plc (NASDAQ:IMCR): Cash Flow
Jun 2023 -2.39M 2.70M 7.35M
Sep 2023 5.11M 2.14M 6.41M
Dec 2023 -8.57M -9.87M 18.08M
Mar 2024 -4.58M -430K 396.01M

Immunocore Holdings alternative data

Immunocore Holdings plc (NASDAQ:IMCR): Employee count
Aug 2023 408
Sep 2023 408
Oct 2023 408
Nov 2023 408
Dec 2023 408
Jan 2024 408
Feb 2024 408
Mar 2024 497
Apr 2024 497
May 2024 497
Jun 2024 497
Jul 2024 497

Immunocore Holdings other data

36.88% -21.99%
of IMCR is owned by hedge funds
16.86M -13.42M
shares is hold by hedge funds

Immunocore Holdings plc (NASDAQ:IMCR): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 4375
Feb 2024 0 120000
Apr 2024 0 4375
Transaction Date Insider Security Shares Price per share Total value Source
Option
ST LEGER TINA AMBER officer: CHIEF HR OFFICER
Employee Share Option (Right to Buy) 4,375 $29.87 $130,681
Option
ST LEGER TINA AMBER officer: CHIEF HR OFFICER
Ordinary Shares 4,375 $29.87 $130,681
Sale
ST LEGER TINA AMBER officer: CHIEF HR OFFICER
Ordinary Shares 4,375 $64.06 $280,263
Option
BERMAN DAVID M officer: HEAD OF R&D
Employee Share Option (Right to Buy) 36,509 $17.46 $637,447
Option
BERMAN DAVID M officer: HEAD OF R&D
Ordinary Shares 36,509 $17.46 $637,447
Sale
BERMAN DAVID M officer: HEAD OF R&D
Ordinary Shares 16,900 $67.61 $1,142,609
Sale
BERMAN DAVID M officer: HEAD OF R&D
Ordinary Shares 7,472 $68.84 $514,372
Sale
BERMAN DAVID M officer: HEAD OF R&D
Ordinary Shares 10,937 $69.73 $762,637
Sale
BERMAN DAVID M officer: HEAD OF R&D
Ordinary Shares 1,200 $70.45 $84,540
Option
BERMAN DAVID M officer: HEAD OF R&D
Employee Share Option (Right to Buy) 54,938 $17.46 $959,217
Thursday, 26 December 2024
zacks.com
Monday, 23 December 2024
zacks.com
globenewswire.com
Friday, 13 December 2024
benzinga.com
Thursday, 12 December 2024
zacks.com
zacks.com
Tuesday, 3 December 2024
globenewswire.com
Thursday, 28 November 2024
zacks.com
Tuesday, 26 November 2024
zacks.com
Monday, 11 November 2024
marketbeat.com
Friday, 8 November 2024
zacks.com
globenewswire.com
Wednesday, 6 November 2024
globenewswire.com
Tuesday, 5 November 2024
zacks.com
Saturday, 14 September 2024
globenewswire.com
Thursday, 12 September 2024
globenewswire.com
Friday, 30 August 2024
seekingalpha.com
Monday, 12 August 2024
seekingalpha.com
Sunday, 11 August 2024
seekingalpha.com
Tuesday, 6 August 2024
investorplace.com
Saturday, 1 June 2024
globenewswire.com
Friday, 31 May 2024
globenewswire.com
Thursday, 30 May 2024
globenewswire.com
Wednesday, 29 May 2024
globenewswire.com
Friday, 24 May 2024
barrons.com
Wednesday, 8 May 2024
globenewswire.com
Wednesday, 24 April 2024
globenewswire.com
Thursday, 4 April 2024
GlobeNewsWire
Friday, 1 March 2024
GlobeNewsWire
Wednesday, 21 February 2024
GlobeNewsWire
  • What's the price of Immunocore Holdings stock today?

    One share of Immunocore Holdings stock can currently be purchased for approximately $32.34.

  • When is Immunocore Holdings's next earnings date?

    Unfortunately, Immunocore Holdings's (IMCR) next earnings date is currently unknown.

  • Does Immunocore Holdings pay dividends?

    No, Immunocore Holdings does not pay dividends.

  • How much money does Immunocore Holdings make?

    Immunocore Holdings has a market capitalization of 1.41B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 73.53% to 249.43M US dollars.

  • What is Immunocore Holdings's stock symbol?

    Immunocore Holdings plc is traded on the NASDAQ under the ticker symbol "IMCR".

  • What is Immunocore Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Immunocore Holdings?

    Shares of Immunocore Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Immunocore Holdings have?

    As Jul 2024, Immunocore Holdings employs 497 workers.

  • When Immunocore Holdings went public?

    Immunocore Holdings plc is publicly traded company for more then 4 years since IPO on 5 Feb 2021.

  • What is Immunocore Holdings's official website?

    The official website for Immunocore Holdings is immunocore.com.

  • How can i contact Immunocore Holdings?

    Immunocore Holdings can be reached via phone at +44 1235 438600.

  • What is Immunocore Holdings stock forecast & price target?

    Based on 5 Wall Street analysts` predicted price targets for Immunocore Holdings in the last 12 months, the avarage price target is $70.2. The average price target represents a 117.06% change from the last price of $32.34.

Immunocore Holdings company profile:

Immunocore Holdings plc

immunocore.com
Exchange:

NASDAQ

Full time employees:

497

Industry:

Biotechnology

Sector:

Healthcare

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

92 Park Drive
Abingdon, OX14 4RY

CIK: 0001671927
ISIN: US45258D1054
CUSIP: 45258D105